TAG:
laboratory consolidation
1998 LIS Sales Rankings Show How Marketplace is Changing
By Robert Michel | From the Volume VI No. 5 – April 5, 1999 Issue
CONSOLIDATION CONTINUED impacting sales of new laboratory information system (LIS) software during 1998. Sales champs in THE DARK REPORT’s annual ranking of the Top Ten LIS Vendors for 1998 are Meditech and Fletcher Flora, in the categories of LIS sales t…
“April 5, 1999 Intelligence: Late Breaking Lab News”
By Robert Michel | From the Volume VI No. 5 – April 5, 1999 Issue
As consolidation of hospital ownership goes, so goes laboratory consolidation. The big trend driving consolidation of hospital ownership is the formation of integrated healthcare systems (IHS). According to SMG Marketing Group, a Chicago-based healthcare information and marketing com…
“March 15, 1999 Intelligence: Late Breaking Lab News”
By Robert Michel | From the Volume VI No. 4 – March 15, 1999 Issue
As expected, the wave of hospital mergers and acquisitions is slowing. During 1998, the number of mergers and acquisitions fell 28% from 1997. This is the first time since 1993 that the number of transactions declined. As reported by the Hospital Acquisition Report, only 144 transactions wer…
Integrating Quest & SBCL Presents a Big Challenge
By Robert Michel | From the Volume VI No. 3 – February 22, 1999 Issue
CEO SUMMARY: Will lessons learned during the commercial lab industry’s consolidation frenzy be learned and applied in the Quest-SBCL merger? History has a way of repeating itself. But Quest Diagnostics’ CEO has a different plan. He also has a tool not utilized by lab executives earlie…
Quest to Pay $1.27 Billion To Buy SB’s Lab Division
By Robert Michel | From the Volume VI No. 3 – February 22, 1999 Issue
CEO SUMMARY: Consolidation is the story of the clinical laboratory industry during the 1990s. The decade will close out with the granddaddy laboratory consolidation of them all! When Quest Diagnostics Incorporated completes its acquisition of SmithKline Beecham Clinical Laboratories later…
Bayer Acquires Chiron In Consolidation Move
By Robert Michel | From the Volume V No. 13 – September 28, 1998 Issue
CEO SUMMARY: As expected, consolidation within the diagnostics industry continues. This time it is Bayer, spending $1.1 billion to acquire Chiron’s diagnostics business. Once completed, Bayer will be the fourth-largest diagnostics company in the world. Laboratory customers of both firms…
Curse Of Consolidation Plagues Health Providers
By Robert Michel | From the Volume V No. 13 – September 28, 1998 Issue
WITHOUT QUESTION, today’s healthcare world is dominated by a single obvious trend: consolidation. The consequences of consolidation affect every segment of healthcare in the United States. The commercial laboratory industry had the dubious distinction of being the first major segment of healthcare…
Consolidation: Threat Or Opportunity
By R. Lewis Dark | From the Volume V No. 13 – September 28, 1998 Issue
IS CONSOLIDATION GOOD OR BAD FOR OUR HEALTHCARE SYSTEM? I don’t know if any of us could accurately answer that question. For better or for worse, big corporations will continue to buy up the little guys. I do feel confident in predicting that ongoing consolidation will occur in all areas of health…
Veterans Administration Network Restructures Using Partnering, Telepathology
By Robert Michel | From the Volume V No. 12 – September 8, 1998 Issue
CEO SUMMARY: Economic pressures are forcing even the traditional and staid Veterans Administration to extensively reconfigure its laboratory services. At this year’s Executive War College in New Orleans, participants learned how one eight-hospi…
Are Pathologists The Next “Fish In The Barrel?”
By R. Lewis Dark | From the Volume V No. 9 – July 6, 1998 Issue
“SHOOTING FISH IN THE BARREL” MAY BE A GOOD METAPHOR TO DESCRIBE what can soon happen to the profession of pathology. This issue of THE DARK REPORT covers several important stories on laboratory management, with direct consequences to pathologists. First, the ISO 9001 certification of the …
CURRENT ISSUE

Volume XXXII, No. 6 – April 21, 2025
Now that a federal judge has vacated the FDA’s LDT rule, The Dark Report analyzes the judgement and notes the various steps the FDA could take in response. Also, lab testing at pharmacies is proving to be less successful than was once anticipated.
See the full table of contentsHow Much Laboratory Business Intelligence Have You Missed?
Lab leaders rely on THE DARK REPORT for actionable intelligence on important developments in the business of laboratory testing. Maximize the money you make-and the money you keep! Best of all, it is released every three weeks!
Sign up for TDR Insider
Join the Dark Intelligence Group FREE and get TDR Insider FREE!
Never miss a single update on the issues that matter to you and your business.
Topics
- Anatomic Pathology
- Clinical Chemistry
- Clinical Laboratory
- Clinical Laboratory Trends
- Digital Pathology
- Genetic Testing
- In Vitro Diagnostics
- IVD/Lab Informatics
- Lab Intelligence
- Lab Marketplace
- Lab Risk & Compliance
- Laboratory Automation
- Laboratory Billing
- Laboratory Compliance
- Laboratory Equipment
- Laboratory Information Systems
- Laboratory Management
- Lean Six Sigma
- Managed Care Contracts
- Molecular Diagnostics
- Pathology Trends
- People
- Uncategorized